( Toronto:TTH, NASDAQ-NMS:TTHI )

News from Transition Therapeutics Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

25 Aug, 2016, 18:46 ET Transition Therapeutics Announces Special Shareholder Meeting Voting Results Including Shareholder Approval of the Plan of Arrangement with OPKO Health, Inc.

TORONTO, Aug. 25, 2016 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) is pleased to...


03 Jun, 2016, 06:01 ET Transition Therapeutics Receives Notification From NASDAQ

TORONTO, June 3, 2016 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) today announced...


11 May, 2016, 16:01 ET Transition Therapeutics Announces Third Quarter Fiscal 2016 Financial Results

TORONTO, May 11, 2016 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (TSX: TTH; NASDAQ: TTHI), a...


25 Apr, 2016, 16:01 ET Transition Therapeutics Announces Dosing of First Patient in Phase 2 Study of Drug Candidate TT701

TORONTO, April 25, 2016 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) today announced the...


17 Mar, 2016, 17:01 ET Transition Therapeutics Receives Notification From NASDAQ

TORONTO, March 17, 2016 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) today announced that...


01 Mar, 2016, 16:30 ET Transition Therapeutics to Present at the 36th Annual Cowen Healthcare Conference

TORONTO, March 1, 2016 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) announced today...


09 Feb, 2016, 16:32 ET Transition Therapeutics Announces Second Quarter Fiscal 2016 Financial Results

TORONTO, Feb. 9, 2016 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (TSX: TTH; NASDAQ: TTHI), a biopharmaceutical...


05 Feb, 2016, 13:01 ET Transition Therapeutics to Hold Conference Call on Second Quarter Fiscal 2016 Financial Results on Tuesday, February 9th, at 4:30 P.M. EST

TORONTO, Feb. 5, 2016 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) will hold a conference...


01 Feb, 2016, 06:01 ET Transition Therapeutics Announces Top Line Phase 2 Clinical Study Results of Diabetes Drug Candidate TT401

TORONTO, Feb. 1, 2016 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) today announced the...


06 Jan, 2016, 06:01 ET Transition Therapeutics Announces Annual General Meeting Voting Results

TORONTO, Jan. 6, 2016 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) announces that the...


19 Nov, 2015, 11:45 ET Transition Therapeutics to Host Investor Day November 23 in New York

Live Webcast Beginning at 12 PM Eastern Time TORONTO, Nov. 19, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company")...


10 Nov, 2015, 16:01 ET Transition Therapeutics Announces First Quarter Fiscal 2016 Financial Results

TORONTO, Nov. 10, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (TSX: TTH; NASDAQ: TTHI), a...


02 Nov, 2015, 06:01 ET Transition Therapeutics to Hold Conference Call on First Quarter Fiscal 2016 Financial Results on Tuesday, November 10th, at 4:30 P.M. EST

TORONTO, Nov. 2, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) will hold a conference...


29 Oct, 2015, 16:01 ET Transition Therapeutics Announces Agreement for Phase 2 Study of TT701 Drug Candidate

TORONTO, Oct. 29, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) announced today that...


28 Oct, 2015, 06:01 ET Transition Therapeutics Announces Presentation of ELND005 Phase 2/3 Clinical Study Results at Clinical Trials in Alzheimer's Disease (CTAD) Conference

TORONTO, Oct. 28, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) announced today that...


15 Oct, 2015, 06:01 ET Transition Therapeutics Announces Results of Data Analysis from ELND005 Phase 2/3 Clinical Study in Agitation and Aggression in Alzheimer's Disease Patients

- Primary efficacy endpoint not achieved in overall study - ELND005 significantly (p value < .05) improved agitation and aggression in...


15 Sep, 2015, 16:01 ET Transition Therapeutics Announces Fiscal 2015 Financial Results

TORONTO, Sept. 15, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (TSX: TTH; NASDAQ: TTHI), a...


14 Sep, 2015, 06:01 ET Transition Therapeutics to Hold Conference Call on Fiscal 2015 Financial Results on Tuesday, September 15th, at 4:30 P.M. EST

TORONTO, Sept. 14, 2015 /CNW/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) will hold a conference call...


12 Feb, 2015, 08:00 ET Transition Therapeutics Inc. Announces Pricing of Public Offering of US$20 Million of Common Shares

TORONTO, Feb. 12, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH)...


11 Feb, 2015, 16:01 ET Transition Therapeutics Inc. Announces Public Offering of Common Shares

TORONTO, Feb. 11, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) announced today that it...


09 Feb, 2015, 16:01 ET Transition Therapeutics Announces Second Quarter Fiscal 2015 Financial Results

TORONTO, Feb. 9, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (TSX: TTH; NASDAQ: TTHI), a...


05 Feb, 2015, 12:00 ET Transition Therapeutics to Hold Conference Call on Second Quarter Fiscal 2015 Financial Results on Monday, February 9th, at 4:30 P.M. EST

TORONTO, Feb. 5, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) will hold a conference...


08 Dec, 2014, 16:35 ET Transition Therapeutics to Present at the Oppenheimer 25th Annual Healthcare Conference

TORONTO, Dec. 8, 2014 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) announced today that Dr....


24 Nov, 2014, 06:01 ET Transition Therapeutics' ELND005 Showed No Prolongation of QT Interval

TORONTO, Nov. 24, 2014 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX:TTH) today announced results...


20 Nov, 2014, 06:01 ET Transition Therapeutics Announces Results from ELND005 Clinical Study in Adults with Down Syndrome

TORONTO, Nov. 20, 2014 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) today announced the...